← Leaderboards
Aj Singhal
Cfd Research Corporation
$2,507,306
Attributed
$2,507,306
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,507,306 · 3
By mechanism
R44$1,626,559 · 1
R43$880,747 · 2
Top collaborators
No co-investigators on record.
Most similar at Cfd Research Corporation
Same institution · by research overlap
- Hanumantharao Paritala$253,024
Others in their field
Other Emerging Leaders on “In Vivo”
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,216,744
- Leonard Freedmand · Leidos Biomedical Research, Inc.$66,248,714
- John Damon Chodera · Sloan-Kettering Inst Can Research$43,427,103
- Tony Moody · Duke University$34,777,314
- Alan D. Palkowitz · Indiana University Indianapolis$18,925,366
Research focus
In VivoStandard Of CareAntimicrobialPre-ClinicalDesignMouse ModelPharmaceutical PreparationsStaphylococcus AureusInfectionProgramsEfficacy StudyRouteDosePre-Investigational New Drug MeetingNatural ProductsIncidenceFlareExhibitsGossypiumEczemaBacteriaAdultImmuneCorynebacterium
Grant awards (6)
Controlled Release Eczema Bandage (CREB)$920,285
R44 · FY2025 · AT · contact PI
A Novel Mechanism of Action Natural Product for Treatment of Drug-Resistant Gonorrhea$289,050
R43 · FY2025 · AI · contact PI
Controlled Release Eczema Bandage (CREB)$50,000
R44 · FY2025 · AT · contact PI
Controlled Release Eczema Bandage (CREB)$656,274
R44 · FY2024 · AT · contact PI
A Novel Mechanism of Action Natural Product for Treatment of Drug-Resistant Gonorrhea$291,697
R43 · FY2024 · AI · contact PI
Development of Inhibitors of cANGPTL4 for Pancreatic Cancer Therapeutics$300,000
R43 · FY2019 · CA · contact PI